(Q44923817)

English

A new treatment for endometriosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

A new treatment for endometriosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

based on heuristic

inferred from title

author name string

P Maouris

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

M Dowsett

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

G Rose

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

D K Edmonds

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

0 references

publication date

1 May 1989

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

8645

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1017-1018

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

New therapy for endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992659-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992659-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992659-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992659-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992659-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(89)92659-7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44923817&oldid=2057886729"